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Abstract
Background: Formation of synaptic connections is a dynamic and highly regulated process. Little
is known about the gene networks that regulate synaptic growth and how they balance stimulatory
and restrictive signals.
Results: Here we show that the neuronally expressed transcription factor gene erect wing (ewg) is
a major target of the RNA binding protein ELAV and that EWG restricts synaptic growth at
neuromuscular junctions. Using a functional genomics approach we demonstrate that EWG acts
primarily through increasing mRNA levels of genes involved in transcriptional and post-
transcriptional regulation of gene expression, while genes at the end of the regulatory expression
hierarchy (effector genes) represent only a minor portion, indicating an extensive regulatory
network. Among EWG-regulated genes are components of Wingless and Notch signaling
pathways. In a clonal analysis we demonstrate that EWG genetically interacts with Wingless and
Notch, and also with TGF-ß and AP-1 pathways in the regulation of synaptic growth.
Conclusion: Our results show that EWG restricts synaptic growth by integrating multiple cellular
signaling pathways into an extensive regulatory gene expression network.
Background
Synaptic connections are formed during development and
continue to be remodeled in the adult nervous system. Such
morphological changes are implicated as the cellular basis of
neuronal information processing and storage in the brain [1].
Although numerous molecules that affect synaptic growth
have been identified, little is known about how expression of
the genes encoding these is orchestrated by cellular signaling
to regulate this form of synaptic plasticity.
Several signaling pathways with prominent roles in develop-
ment have also been shown to regulate synaptic growth.
These include Wnt/Wingless and transforming growth factor
(TGF)-β/bone morphogenetic protein (BMP) signaling path-
ways (reviewed in [2,3]), as well as the jun kinase pathway
[4]. All of these pathways stimulate synaptic growth at neu-
romuscular junctions (NMJs) in Drosophila larvae [5-9], a
model system for synaptic plasticity of glutamergic synapses
[10]. In addition, Notch (N) signaling has recently also been
implicated in plasticity due to impaired memory formation
[11-13]. A major focus of these studies has been the
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identification of the transcription factors regulated by these
signaling cascades. Prominent roles have been attributed to
immediate early genes such as the transcription factors fos
and jun [4,14-16], as well as the SMAD and co-SMAD homo-
logues mad and medea in Drosophila [5-9]. Although much
has been learned about how extracellular signals are trans-
duced to the nucleus and regulate transcription factors, rela-
tively little is known about gene networks and their
organization, and how they operate in response to cellular
signaling to mediate synaptic growth.
To delineate the nuclear response underlying presynaptic
r e g u l a t i o n  o f  s y n a p t i c  g r o w t h  i n  a  Drosophila  model, we
focused on the role of the transcription factor Erect wing
(EWG), a homologoue of human NRF-1 [17,18]. A salient fea-
ture in the regulation of ewg expression is the elaborate con-
trol by ELAV, a post-transcriptional regulator expressed in
neurons of Drosophila  that is required for EWG protein
expression [19-22]. The human homologue of ELAV, HuD,
has previously been implicated in the regulation of synaptic
plasticity [20,23], but the molecular and cellular conse-
quences of increased expression of HuD are largely unknown.
Consistent with a potential role in presynaptically regulating
synaptic growth, EWG protein is expressed in all neurons,
and transiently also in indirect flight muscles [17,24,25]. ewg
mutant embryos are unable to exhibit coordinate larval
movements and fail to hatch.
Here we show that the transcription factor gene ewg  is a
major target of the RNA binding protein ELAV and that EWG
restricts synaptic growth at NMJs. This novel pathway prima-
rily acts through EWG-up-regulated genes involved in either
transcriptional or post-transcriptional regulation of gene
expression. Analysis of synaptic growth in mutants of genes
differentially regulated in ewgl1mutants shows that these
genes are involved in both stimulatory and restrictive path-
ways. We further show that ewg genetically interacts with
multiple signaling pathways in synaptic growth regulation in
Drosophila. Our data suggest, therefore, that multiple cellu-
lar signaling pathways are connected with EWG regulation of
synaptic growth in an extensive regulatory gene network.
Results
Erect wing restricts synaptic growth at neuromuscular 
junctions
To examine ewg mutants for synaptic growth defects at third
instar NMJs, we used a clonal analysis strategy in mosaic ani-
mals. For this analysis we made the following rescue con-
struct, termed eFeG. The ewg cDNA was flanked by FRT sites
and fused to an elav promoter. To visualize recombination,
the sequence of yeast GAL4 was inserted downstream of the
FRT-ewg-FRT cassette. FLP/FRT mediated recombination
will result in loss of the ewg cDNA and lead to expression of
GAL4 in neurons that can be visualized in the presence of a
UAS-CD8::GFP  transgene (Figure 1a,c,e-i) [17,24,25]. The
functionality of eFeG is shown in a clone induced in photore-
ceptor neurons in ewgl1, a null allele [24]. Upon loss of the
ewg cDNA in the clone, CD8::GFP is expressed and EWG
expression is lost (Figure 1b,c). For the analysis of third instar
NMJs, recombination was induced in late embryogensis (14-
16 h after egg laying). Larvae bearing EWG null clones move
indistinguishably from their balancer carrying siblings,
pupate normally and many adults hatch. These adults are,
however, impaired in walking.
At third instar NMJs, EWG deficient motorneurons have an
increased number of synaptic boutons that look morphologi-
cally normal as visualized with an antibody against synapto-
tagmin, a marker for synaptic vesicles [26] (Figure 1d-i).
Quantification of type 1b boutons at muscle 13 revealed about
an 85% increase in bouton number (p < 0.0001; Figure 1j)
compared to wild-type or balancer carrying siblings contain-
ing one wild-type copy of ewg (rec. control in Figure 1j). Since
ewg is located on the X chromosome and we used males, we
also quantified type 1b bouton numbers at muscle 13 in
ewgl1females transheterozygous for a hypomorphic P  ele-
ment insertion, P{lacW}ewgG1518 (18.8 ± 0.45, n = 18, p <
0.0001 for comparison with wild type). Significant effects
were also observed at muscles 4, 6/7 and 12 (29%, 30% and
45% increase compared to wild type, p ≤ 0.001). Besides over-
growth, NMJs of EWG deficient clones appeared normal and
staining with markers for active (Nc82) and periactive (High-
wire) zones, for microtubules (Mab 22C10) or post-synaptic
specializations (anti-DLG) did not reveal obvious differences
(Figure 1k-n and data not shown). The role of EWG in synap-
Erect wing restricts synaptic growth at third instar neuromuscular junctions Figure 1 (see following page)
Erect wing restricts synaptic growth at third instar neuromuscular junctions. (a) Schematic of the eFeG construct used for clonal analysis of ewgl1, an 
embryonic lethal allele. (b,c) FLP/FRT mediated recombination in photoreceptor neurons in third instar larval eye disc. Note that CD8::GFP is expressed 
(c) in the ewgl1clone (b). The scale bar in (c) is 25 μm. (d-i) NMJs of control and ewgl1clones in third instar larvae. Clones of controls (d-f, in ewgl1eFeG/+; 
hs-flp/+ UAS-CD8::GFP/+ females, rec. control in (j)) and of ewgl1(g-i, in ewgl1eFeG/Y; hs-flp/+ UAS-CD8::GFP/+ males) were stained with anti-SYT or with anti-
CD8 antibodies to visualize synaptic growth defects of type 1b boutons at muscle 13. The scale bar in (i) is 20 μm. (j) Quantification of synaptic growth 
defects in ewgl1mutant neurons. Shown are means of bouton numbers (type 1b at muscle 13) with standard errors (n = 21-35). Rec. control refers to 
clones made in the presence of one copy of ewg+ as in ewgl1eFeG/+; hs-flp/+ UAS-CD8::GFP/+ females. Tetanus toxin was expressed from a UAS transgene in 
clones by the recombined eFeG construct. Statistical significance of differences from comparisons with wild type is shown on top of bars (***p < 0.0001, 
**p < 0.001, n.s. for non significant). Other relevant comparisons are marked by horizontal bars with the statistical significance indicated on the side. (k-n) 
Distribution of synaptic markers is normal at ewgl1NMJs. Active zones were stained with anti-Nc82 at wild type (k) or ewgl1NMJs (m) and periactive zones 
were stained with anti-Highwire at wild type (l) or ewgl1NMJs (n). The scale bar in (n) is 1 μm.http://genomebiology.com/2008/9/4/R73 Genome Biology 2008,     Volume 9, Issue 4, Article R73       Haussmann et al. R73.3
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tic growth regulation is cell-autonomous, since bouton num-
bers of non-recombined neurons in mosaic animals were
indistinguishable from wild type (data not shown). Inhibition
of synaptic transmission by expression of tetanus toxin in
EWG deficient neurons did not affect overgrowth, demon-
strating that overgrowth is not a result of compensatory sig-
nals from the muscle due to changes in neuronal activity
(Figure 1j). Similarly, expression of tetanus toxin also did not
affect synaptic growth in wild-type clones (Figure 1j).
To demonstrate that synaptic overgrowth of EWG deficient
neurons is a result of ewg loss of function (LOF), we added a
rescue construct where an elav  promoter drives the ewg
cDNA (elav-EWG) [17]. Presence of this construct signifi-
cantly reduced the number of type 1b boutons at muscle 13
compared to EWG deficient neurons (p < 0.0001; Figure 1f),
but rescue is not complete compared to wild-type neurons (p
< 0.001; Figure 1f). Since ewg  is strongly homologous to
human NRF-1 (80% in the DNA binding domain [18]), we
tested if expression of NRF-1 under an elav promoter can res-
cue the synaptic growth defect of ewg. elav-NRF-1 transgenes
fully rescued synaptic growth defects of ewgl1mutants (p <
0.0001), resulting in bouton numbers that were not signifi-
cantly different from wild type (Figure 1j). elav-NRF-1 trans-
genes also fully rescued embryonic lethality of ewgl1mutant
embryos (89 ± 8%, n = 5 independent transgene insertions).
ewgl1elav-NRF-1 animals develop to pharate adults, but fail
to hatch.
Since ewg LOF results in synaptic overgrowth, we wanted to
know if overexpression of ewg results in reduced synaptic
growth. To separate ewg function in early neuronal differen-
tiation from its role in synaptic growth regulation and to
apply physiological concentrations of EWG, we used an
inducible neuron-specific GAL4 driver (elav-GeneSwitch-
GAL4, elav-GS-GAL4 [27]) to express EWG from a UAS-ewg
transgene. Concentration dependent inducibility of the elav-
GS-GAL4 was verified by western blots (Figure 2a). At NMJs,
numbers of type 1b boutons at muscle 13 were about 30%
reduced compared to wild type, and at muscle 12 about 45%
reduced (p < 0.0001; Figure 2b-d) when EWG expression was
about two-fold increased compared to wild type (Figure 2a,
lane 3 versus lane 2). Higher expression levels of EWG did not
further reduce synaptic growth, but resulted in pupal
lethality. Controls with induced elav-GS-GAL4 (but no UAS-
ewg), or UAS-ewg alone had wild-type bouton numbers (data
not shown).
ewg is a major ELAV target in post-embryonic 
development
In the presence of the RNA binding protein ELAV, the last
ewg intron is spliced, resulting in expression of EWG protein
[19,21]. Since the ewg gene encodes a transcription factor,
EWG could potentially regulate a large portion of genes that
are also regulated by ELAV, and therefore rescue elav
mutants. To test if elav mutants are rescued by EWG, we used
animals transheterozygous for the elavts1temperature sensi-
tive allele and for the null allele elave5[28]. When early func-
tions of ELAV in neuronal differentiation were allowed by
rearing embryos at the permissive temperature, elav-EWG
fully rescued the lethality of elavts1/elave5flies (Figure 3a).
The rescued elavts1/elave5;  elav-EWG  animals, however,
Conditional overexpression of ewg reduces synaptic growth Figure 2
Conditional overexpression of ewg reduces synaptic growth. (a) Western blot of EWG in larval brains upon induced expression. EWG levels in larval 
brains were compared between elav-GS-GAL4 UAS-ewg animals fed with RU486 (1.2, 4.8 and 19.2 μg/10 ml food, lanes 3-5) and uninduced animals (lane 2), 
and to adult heads (lane 1). Note that a two-fold overexpression of EWG is effective to reduce synaptic growth (lane 3) compared to wild type (lane 2). 
(b,c) NMJs of control and EWG overexpressing animals. Shown are NMJs at muscle 13 of uninduced (b) or induced (c, 1.2 μg RU486/10 ml food) elav-GS-
GAL4 UAS-ewg animals stained with anti-HRP antibodies. The scale bar in (b) is 20 μm. (d) Quantification of synaptic growth defects with excess EWG. 
Shown are means of bouton numbers (type 1b at muscle 13) with standard errors (n = 12-15) of uninduced (b) or induced (c, 1.2 μg RU486/10 ml food) 
elav-GS-GAL4 UAS-ewg animals. Statistically significant differences are indicated by asterisks (***p < 0.0001).
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showed motor defects and were flightless, suggesting that the
RNA binding protein ELAV regulates additional genes. Given
the prominent NMJ phenotype of ewg  mutants, we next
tested if ELAV is also involved in regulating synaptic growth.
At NMJs, elavts1/elave5animals showed a significant reduc-
tion of bouton numbers compared to wild type (p < 0.0001;
Figure 3c,f), a phenotype opposite to the ewg mutant pheno-
type. Synaptic growth defects of elavts1/elave5animals, how-
ever, were fully rescued to wild-type levels by an elav-EWG
transgene (p < 0.0001 for elavts1/elave5; elav-EWG compared
with elavts1/elave5and not significantly different from wild
type; Figure 3d,f). As expected, an elav-ELAV transgene also
fully rescued synaptic growth defects of elavts1/elave5animals
(p  < 0.0001 for elavts1/elave5;  elav-ELAV  compared with
elavts1/elave5and not significantly different from wild type;
Figure 3d,f). These results indicate overlapping stimulatory
and restrictive pathways in regulating synaptic growth that
are integrated through the transcriptional regulator EWG
(see below). Boutons in elavts1/elave5animals appeared nor-
mal and staining with markers for active (Nc82) and periac-
tive (Highwire) zones, for microtubules (Mab 22C10) or post-
synaptic specializations (anti-DLG) did not reveal obvious
differences (data not shown).
Identification of genes differentially regulated in 
ewgl1mutants
To assess how the transcription factor EWG regulates synap-
tic growth, we identified genes differentially regulated in
ewgl1mutants using cDNA microarrays. We hand-selected
ewgl1late stage embryos that differ from their siblings by the
lack of green fluorescent protein (GFP), extracted and ampli-
f i e d  p o l y A  R N A ,  a n d  h y b r i d i z e d  c D N A  m i c r o a r r a y s .  T o
exclude genes differentially regulated due to genetic back-
ground and to validate genes differentially regulated in
ewgl1mutants at a genomic scale, we included ewgl1animals
rescued by elav-EWG. From these experiments (n = 4, except
for ewgl1n = 5), mRNA expression levels of 107 genes were
significantly down-regulated (Figure 4c) and of 107 genes
were significantly up-regulated (Figure 4d) in ewgl1embryos
(p ≤ 0.01; changes in expression levels are shown in Table S3
of Additional data file 1) compared to both wild-type and
ewgl1elav-EWG embryos. Quantitative RT-PCR analysis from
selected genes that were down-regulated (Ac3,  CG7646,
Erect wing rescues viability and synaptic growth defects of elav mutants Figure 3
Erect wing rescues viability and synaptic growth defects of elav mutants. (a) Rescue of viability of elav mutants by ewg transgenes. An elav-EWG transgene 
fully rescues viability of a temperature sensitive elav allele (elavts1transheterozygous for the elave5, a null allele); when early functions in neuronal 
differentiation are provided by rearing flies at the permissive temperature (three days at 18°C and then at 25°C, n = 250-350 animals per genotype). (b-f) 
Rescue of synaptic growth defects of elav mutants by EWG. Synaptic growth in elavts1/elave5mutants (c,f) is significantly reduced (p ? 0.0001) when reared at 
the restrictive temperature during larval life compared to wild type (b,f) and is rescued by elav-EWG (d,f) and elav-ELAV (e,f). Bouton numbers (type 1b at 
muscle 13) in (f) are shown as means with standard errors (n = 21-35). Statistical significance of differences from comparisons with wild type is shown on 
top of bars (***p < 0.0001, n.s. for non significant). Other relevant comparisons are marked by horizontal bars with the statistical significance indicated on 
the side. The scale bar in (b) is 20 μm.
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CG1909,  Srca) or up-regulated (Pepck,  osi14,  CG5171,
CG10585) in ewgl1mutant embryos further confirmed the
findings from the microarray expression analysis (Figure 4e),
for example, expression levels were reduced or increased in
ewgl1mutant embryos compared to the control gene elav, but
restored to wild-type levels in the presence of the elav-EWG
transgene.
Clustering differentially regulated genes revealed that down-
regulated genes fall into several functional classes with a pref-
erence for genes involved in the regulation of gene expression
(40%, 43 of 107; Figure 4a,c), while up-regulated genes are
enriched for genes involved in basic cellular metabolism
(47%, 50 of 107; Figure 4b,d). Surprisingly, only a minor por-
tion of genes (4%, 8 of 214; Figure 4c,d) could be loosely
defined as 'neuronal effector genes' (genes at the end of the
regulatory expression hierarchy in neurons and associated
with neuron specific functions) with known or potential
functions in synaptic growth regulation, for example, Ac3,
encoding an adenylyl cyclase, CG1909, encoding a Dro-
sophila Rapsyn homologue, CG7646, encoding a Ca2+ sensor,
and the gene encoding Henna, a phenylalanine hydroxylase
involved in dopamine and serotonin synthesis. Candidates for
mediating the synaptic growth phenotype from the remaining
Genes differentially regulated in late embryos of ewgl1mutants Figure 4
Genes differentially regulated in late embryos of ewgl1mutants. (a,b) Functional classification of genes differentially regulated in late embryos of 
ewgl1mutants. Down-regulated (a) and up-regulated (b) genes were classified according to Gene Ontology processes. (c,d) List of genes differentially 
regulated in late embryos of ewgl1mutants, giving functional classification and nervous system expression. Hierarchical clustering of normalized expression 
levels of down-regulated (c) and up-regulated (d) genes in ewgl1embryos compared with wild type and ewgl1embryos rescued with elav-EWG. Gene names 
and functional categories are shown to the right together with nervous system expression data determined by RNA in situ hybridization (+, expressed in 
the nervous system; -, not expressed in the nervous system; n.s., no staining; n.d., not determined). Differential expression is visualized by blue (down-
regulation) and red (up-regulation). (e) Quantitative RT-PCR of selected genes differentially regulated in ewgl1mutants. PCR products using 32P labeled 
forward primers from genes up-regulated in ewgl1mutants Ac3, CG7646, CG1909 and Srca (cycles 28, 24, 28 and 28), and from genes down-regulated in 
ewgl1mutants Pepck, osi14, CG5171 and CG10585 (cycles 26) were analyzed on 6% polyacrylamide gels. elav: control (cycle 28).
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CG7288  Ubiquitin carboxyl-terminal hydrolase family2, P  n.s.
CG3455 Rpt4, endopeptidase, proteasome regulatory particle, P  + 
CG6297 Jil1, kinase, phosphorylates histone H3, CR  n.d.
CG10241 Cyp6A17 +   M   , 7 1 A 6   e m o r h c o t y c   ,
CG4184 Arc105 . d . n   T   , r o t a i d e m   n o i t p i r c s n a r t   I I l o P   ,
. s . n   U   0 1 9 0 1 G C
+   R   , t n e n o p m o c   P N R   , n i a m o d   r o d u T   9 8 5 8 G C
CG9999 Sd, Segregation distorter, nucleocytoplasmic transport, R  + 
. d . n   U   6 4 4 2 G C
. d . n   S   , n i l a c o p i L   , n i e t o r p   g n i d n i b   d i p i L   7 0 8 5 G C
. d . n   M   , e s a n e g o r d y h e d   e n i l o h C   1 2 5 9 G C
. s . n   M   , e s a r e f s n a r t l y h t e M   6 9 5 1 1 G C
CG6875 Asp, abnormal spindle, microtubule bound kinase, CC  + 
. d . n   T   , r o t c a f   n o i t p i r c s n a r T   5 2 5 3 3 G C
CG5300 Kpl31E . s . n   C S   , n i s e n i K   ,
+   R   , 5 S   n i e t o r p   l a m o s o b i R   4 1 0 7 G C
+   R   , g n i d n i b   A N R   0 5 7 2 1 G C
. s . n   T   , r o t c a f - o c   n o i t p i r c s n a r T   5 3 8 5 1 G C
CG8548 karyopherin alpha1 . s . n   R   , t r o p m i   r a e l c u n   ,
+   R   , t n e n o p m o c   e r o p   r a e l c u N   2 9 0 1 1 G C
CG1438 Cyp4c3 . d . n   M   , 3 c 4   e m o r h c o t y c   ,
CG9682 Rpl24 +   R   , n i e t o r p   l a m o s o b i r   ,
. s . n   M   , e s a r e f s n a r t l y s o c y l G - P D U   7 9 7 3 G C
. d . n   U   9 3 1 1 3 G C
. s . n   N   , g n i s s e c o r p   e n o m r o h   e d i t p e P   8 6 1 1 G C
CG7398 Trn . d . n   R   , t r o p m i   r a e l c u n   , n i t r o p s n a r t   ,
. d . n   U   9 9 5 3 1 G C
CG8203 Cdk5 +   N   , e s a n i k   t n a d n e p e d   n i l c y c   ,
CG17252 BCL7-like +   U   ,
. d . n   U   0 3 2 3 1 G C
. s . n   R   , g n i d n i b   d i c a   c i e l c u n   d e d n a r t s - e l g n i S   8 0 6 2 G C
. d . n   U   1 1 3 6 G C
. s . n   U   2 5 3 8 G C
CG1909 dRapsyn , acetylcholine receptor clustering, N  n.d.
CG4118 nxf2 -   R   , 2   r o t c a f   t r o p x e   A N R   r a e l c u n   ,
. d . n   M   , n i e t o r p o n e l e s   D h t B   7 7 1 1 1 G C
CG5422 Rox8 +   R   , n i e t o r p   g n i d n i b   A N R   ,
CG9327 Pros29 . d . n   P   , t i n u b u s   a D k   9 2   m o s a e t o r p   ,
CG13399 Chrac-14, nucleosome mobilization complex, CR  n.s.
CG9556 Alien , signalosome subunit (protein degradation), P  -
. d . n   U   5 6 5 4 1 G C
CG9393 metaxin1 , mitochondrial protein import, P  n.s.
-   C S   , n o i s e h d a   l l e C   7 2 2 7 G C
CG2803 Tina-1     . d . n   C S   , 1   n i k a   C   n i n o p o r r t   ,
CG6347  Papain cystein protease (C1), NOT cathepsin L activity, M  - 
-   M   , e s a t a h p s o h p   e t a h p s o h p   6 - e s o l a h e r T   1 7 1 5 G C
CG15592 Osiris 9     -   M   ,
-   U   1 6 9 2 G C
-   U   6 5 7 4 1 G C
. d . n   S   , e s a t a h p s o h p   n i e t o r P   6 4 7 6 G C
CG11312  insc , inscuteable , cytosceletal adaptor protein, SC  +
CG9083  Cuticular component (eggshell homology), SC  -
-   U   9 5 1 3 1 G C
CG1155   Osiris 14     -   M   ,
. s . n   U   0 1 3 2 1 G C
CG15189 Osiris 19     +   M   ,
CG1151   Osiris 6     -   M   ,
. d . n   M   , e s a e t o r p   e k i l - n i s p y r T   3 1 2 8 G C
-   U   6 0 3 4 G C
CG16796   Hydroxymethylglutaryl-CoA synthase, cholesterol metabol., M  -
. d . n   U   1 1 4 9 G C
. s . n   C S   , n i e t o r p   r o t p a d A   0 4 7 5 1 G C
CG1153 Osiris  7     -   M   ,
    -   C S   , n i e t o r p   r o t p a d a   t a e p e r   D W   4 2 7 6 G C
CG18559 Cyp309a2 . d . n   M   , 2 a 9 0 3   e m o r h c o t y c   ,
. d . n   U   3 3 2 2 G C
-   M   , e s a t a h p s o h p i b - 6 , 1 - e s o t c u r F   1 1 6 0 1 G C
CG18108 Im1 . s . n   I   , 1   e l u c e l o m   d e c u d n i   e n u m m i   ,
CG7399 Henna +   N   , e s a l y x o r d y h   e n i n a l a l y n e h p   ,
CG8869 Jon25bii . s . n   M   , e s a n i e t o r p o d n e   e p y t   n i r e s   ,
. d . n   U   0 7 4 5 G C
CG3481 Adh . d . n   M   , e s a n e g o r d y h e d l o h o c l a   ,
-   M   , m s i l o b a t e m   d i p i l   , e s a t a h p s o h p   e n i l a k l A   7 4 1 8 G C
. d . n   M   , e s a d i t p e p o d n e o l a t e M   4 5 2 5 1 G C
CG6633 Ugt86Dd, glucoronosyltransferase, lipid metabolism, M  n.d. 
. d . n   M   , e s a n e g o r d y h e d   e d y h e d l A   2 5 7 3 G C
-   M   , e s a p i l   e d i r e c y l g i r T   6 8 1 9 G C
CG10254 Cyp6a20 . d . n   M   , 0 2 a 6   e m o r h c o t y c   ,
. d . n   M   , e s a n e g o r d y h e d   e t a r t i c o s I   6 7 1 7 G C
CG7230 ribbon -   T   r o t c a f   n o i t p i r c s n a r t   ,
CG13297 Cyt-b5-r , cytochrome b5, electron transport, M  -
CG9370 omega -   M   , V I   e s a d i t p e p   l y d i t p e p i d   ,
. d . n   M   , e s a d i x o r e P   1 1 2 0 1 G C
. d . n   U   5 1 6 5 1 G C
. d . n   C S   , n i e t o r p   e l u c i t u C   6 7 0 7 G C
CG17725 Pepck, phosphoenolpyrovat carboxykinase, M  -
+   U   3 6 4 1 G C
CG10717 ImpL1 -   U   , 1 L   e n e g   e l b i c u d n i - n o s y d c e   ,
CG33009  Mevalonat kinase, isoprenyl metabolism, M  n.d.
CG9390 AcCOAS, acetyl CoA synthase, lipid biosynthesis, M  n.d.
CG10585  Trans-hexaprenyltransferase (terpenoid synthase), M  -
-   M   , e s a r e f s n a r t s n a r t l y n e r p a x e h - s n a r T   4 8 6 3 G C
. d . n   M   , e s a r e f s n a r t l y t e c A   2 2 5 1 3 G C
. d . n   M   , e s a d i x o r e P     1 3 1 3 G C
CG5575 ken -   T   , r o t c a f   n o i t p i r c s n a r t   ,
-   C S   , n i e t o r p   e l c i t u c   l a v r a L   8 5 4 6 G C
-   C S   , n i e t o r p   e l c i t u c   l a v r a L   8 3 6 8 G C
. d . n   U   9 3 2 5 1 G C
-   U   0 8 4 5 G C
. d . n   U   6 2 0 6 G C
CG15188 Osiris 20 -   M   ,
CG10546 Cralbp , cellular retinaldehyd binding protein, lipid carrier, M  n.d. 
. d . n   U   4 6 1 2 1 G C
-   U   8 4 5 2 3 G C
CG1629 yellow-h -   M   ,
CG9847 Fkbp13, peptidyl-prolyl cis-trans isomerase, S  n.d.
CG6816 Cyp18a1 -   M   , 1 a 8 1   e m o r h c o t y c   ,
. d . n   M   , e s a t e h t n y s   d i c a   y t t a F   3 2 5 3 G C
CG1157 Osiris  15     -   M   ,
+   M   , e s a t c u d e r o d i x O   5 7 6 7 G C
-   U   5 0 0 5 1 G C
-   U   9 3 6 4 1 G C
CG8867 Jon25bi . s . n   M   , 4   e s a e t o r p   e n i r e s   ,
CG1934 ImpE2 -   U   , 2 E e n e g   e l b i c u d n i - n o s y d c e   ,
    . d . n   U   4 2 3 1 3 G C
-   C S   , n i e t o r p   e l c i t u c   l a v r a L   9 2 0 2 3 G C
-   M   , e s a r u t a s e d   1 1 a t l e d   A o C - l y c A   7 4 7 9 G C
CG18321 miple2 -   S   , r o t c a f   h t w o r g   ,
. d . n   U   7 3 7 3 1 G C
-   T   , r o t c a f   n o i t p i r c s n a r t   r e g n i f c n i Z   0 0 8 3 G C
CG4445 pgant3 , polypeptide GalNAc transferase3, M  n.d.
-   C S   , t n e n o p m o c   e n a r b m e m   c i h p o r t i r e P   2 5 0 7 1 G C
+   R   , e s a c i l e h A N R - H A E D / D A E D   7 7 0 0 1 G C
CG9148 Scf -   R C   , r o t c a f   g n i l i o c r e p u s   ,
CG4758 Trp1, translocation protein 1, SRP-dep. membrane targeting, P  -
CG8896 18wheeler , cell adhesion, chemokine and cytokine signaling, SC  + 
+   M   , t r o p m y s   , r e t r o p s n a r t   e n i l o r P - a N   8 0 7 7 G C
CG6155 Roe1 . d . n   M   , e n o r e p a h c   l a i r d n o h c o t i m   ,
-   P   , s i s e h t n y s   n i e t o r p   d e t c e r i d   R E   1 0 7 2 3 G C
-   U   2 2 0 5 1 G C
. d . n   M   , s i s e h t n y s   d i c a   y t t a f   n i a h c - g n o l - y r e V   2 2 5 1 3 G C
CG7279 Lip1 -   M   , e s a p i l   l o r e c y l g l y c a i r t   ,
-   M   , e s a t c u d e r o d i x O   6 0 3 8 G C
CG8434 lambik . d . n   C S   , n o i s e h d a   l l e c   ,
CG2781  1,3-beta-glucan synthase, fatty acid elongation, M  -
. d . n   C S   , n o i s e h d a   l l e C   6 9 8 7 G C
CG3903 Gli, Gliotactin , cell adhesion, component of septate junction, SC  + 
CG18485 Stumps , scaffolding protein involved in FGF signaling, SC  - 
+   M   , n i e t o r p   r e i r r a c   d i p i l   , 3 e n i k o r e h P   8 5 3 9 G C
. d . n   U   7 4 1 4 1 G C
-   C S   , n o i s e h d a   l l e C   5 1 1 4 G C
-   U   7 7 7 3 G C
+   M   , e k i l   e s a t c u d e r   n i x o d o r r e F   0 6 0 4 G C
. d . n   U   6 8 9 8 G C
-   M   , g n i d n i b   l a n i t e R   7 5 6 0 1 G C
. d . n   M   , e s a r e f s n a r t   e n o i h t a t u l G   1 8 6 1 G C
. d . n   C S   , n i e t o r p   e l c i t u c   l a v r a L   7 0 0 5 1 G C
CG11212   Ptr . d . n   S   , r o t p e c e r   d e t a l e r - c t P   ,
CG2150  Cuticular component (eggshell homology), SC  -
(a)
(b)
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functional classes include groucho (gro), encoding a tran-
scriptional repressor of Wg and N signaling, and genes encod-
ing a number of cell adhesion molecules (CG7227,  18w,
CG8434, CG7896, Gli, CG4115).
Synaptic growth defects in ewg mutants are cell-autonomous,
suggesting that differentially expressed genes involved in reg-
ulating synaptic growth are also expressed in the nervous sys-
tem. We therefore analyzed RNA expression patterns in late
stage embryos from a representative number of genes differ-
entially regulated in ewgl1mutants (66%, 74 down- and 68
up-regulated genes; RNA in situ expression patterns are
mostly available from the Berkeley Drosophila  Genome
Project (BDGP)). RNA in situ hybridization experiments
revealed that 86% (42 of 52) of down-regulated genes in
ewgl1mutants, but only 17% (11 of 63) of up-regulated genes in
ewgl1mutants, are expressed in the nervous system of late
stage embryos (Figure 4c,d; Figures S2 and S3 in Additional
data file 1). Interestingly, these RNA in situ hybridization
experiments further revealed that the vast majority of genes
down-regulated in ewgl1mutants are broadly expressed in the
entire nervous system, suggesting that they might be direct
targets of EWG. From those genes where the RNA expression
pattern was analyzed, 30% (22 of 74) of down-regulated
genes in ewgl1mutants and 7% (5 of 68) of up-regulated genes
in ewgl1mutants did not yield a signal in RNA in situ experi-
m e n t s ,  a l t h o u g h  t h e y  w e r e  d e t e c t e d  o n  m i c r o a r r a y s  a t
comparable levels. These transcripts might reside, therefore,
in tightly packed mRNP particles and not be accessible to in
situ hybridization after fixation, which has been shown, for
example, for Fragile X Mental Retardation Protein (FMRP)
mRNA in dendrites [29].
Analysis of synaptic growth in mutants of genes 
differentially regulated in ewgl1mutants
Recent efforts in Drosophila genome projects have increased
the number of mutants to cover 50-60% of all protein coding
genes [30-34]. This allows for a functional genomics
approach to identify a representative fraction of genes differ-
entially regulated in ewgl1mutants and involved in synaptic
growth regulation, and to elucidate general principles that
operate in this biological process. We obtained viable
mutants for 42% (40 of 95) of genes down-regulated in
ewgl1mutants and for 37% (23 of 62) of genes up-regulated in
ewgl1mutants (Table S2 in Additional data file 1). Focusing on
synaptic growth regulation, we restricted our analysis to
genes not involved in basic cellular metabolism unless their
expression was enriched in the nervous system. Most of the
mutants were P element or piggyBAC insertions in promotor
regions and represent hypomorphic alleles indicated by 38%
(21 from 57) showing adult phenotypes (pupal lethality, mor-
phological aberrations, sterility or flightlessness; Table S2 in
Additional data file 1) as transheterozygotes over a deficiency
or a second allele. A minor portion of mutants was embryonic
or early larval lethal (10%, 7 of 70) and could not be analyzed
for synaptic growth defects. Viable mutants tend to
accumulate genetic modifiers [35]. Therefore, we normalized
the genetic background by analyzing transheterozygotes for a
chromosomal deficiency, or in some cases transheterozygotes
for a second allele. Since the most pronounced effect in
ewgl1mutants was at muscle 13, we quantified type 1b boutons
at muscle 13.
Analysis of synaptic growth in mutants of genes down- and
up-regulated in ewgl1mutants revealed that 85% (34 of 40)
and 70% (16 of 23), respectively, were associated with statis-
tically significant differences in synaptic growth compared to
controls (Figure 5, y w line and y w transheterozygous for
appropriate deficiencies, p ≤ 0.0001 for the vast majority; for
details, see Table S2 in Additional data file 1). Ninety percent
(18 of 20) of the genes down-regulated in ewgl1mutants are
also expressed in the nervous system (Figure 5a,c). Clustering
these genes into functional classes revealed a strong enrich-
ment for genes involved in the regulation of gene expression
(65%, 22 of 34; Figure 5a,c). In contrast, genes up-regulated
in ewgl1mutants with synaptic growth defects are mostly not
expressed in the nervous system (64%, 7 of 11; Figure 5b,c)
and are split into many different functional classes (Figure
5b,c).
For both down- and up-regulated genes in ewgl1mutants with
synaptic growth defects, phenotypes could be split into
groups with either more or less boutons (Figure 5). Among
those genes down-regulated in ewgl1mutants with growth
defects in mutants, 29% (10 of 34) had the same overgrowth
phenotype as ewgl1mutants (Figure 5a). These results show
that EWG-regulated gene expression combines both stimula-
tory and restrictive functions in synaptic growth regulation,
and that restrictive functions dominate, indicated by the
overgrowth phenotype of ewgl1mutants.
Based on synaptic growth phenotypes associated with
mutants of genes differentially regulated in ewgl1mutants, the
following model assigns more distinct roles to these genes in
the context of EWG regulation (Figure 5c). Genes down-reg-
ulated in ewgl1mutants with an increased number of boutons
exert restriction on synaptic growth in the presence of EWG,
while those genes down-regulated in ewgl1mutants with a
reduced number of boutons in mutants might provide a
trophic supply for synaptic growth. For genes up-regulated in
ewgl1mutants, overgrowth associated with mutations in these
genes is indicative of a role in expansion of synaptic growth as
they are repressed in the presence of EWG. This class includes
primarily cell adhesion molecules for which a restrictive role
has been demonstrated when adhesion has been increased
(for example, [36]). Most genes up-regulated in ewgl1mutants
with fewer boutons are not expressed in the nervous system.
These genes might, therefore, be regulated endocrinologi-
cally, indicated by the role of ewg in regulating metabolic
aspects.Genome Biology 2008, 9:R73
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Erect wing co-regulated genes are functionally related
Pioneering work in yeast has shown that expression of func-
tionally related genes is co-regulated (reviewed in [37]). We
therefore used genetic interaction experiments to test for
functional connections among genes that are differentially
expressed in ewg mutants and that are also involved in syn-
aptic growth regulation. Since loss of ewg results in more
boutons and synaptic overgrowth can be further induced (for
example, by overexpression of the fos and jun heterodimer
AP-1, see below), we analyzed double mutants in a represent-
ative number of those genes down-regulated in ewgl1mutants
with more boutons. For all different combinations tested,
none of the double mutant animals had more boutons than
the single mutants, indicating that these genes do not act in
parallel to regulate synaptic growth as independent effects
would be additive (Table S1 in Additional data file 1). Some
combinations, however, resulted in significant reduction of
bouton numbers (for example,Ac3; Bcl7-like, Ac3; CG1943,
and Bcl7-like; CG12299; Table S1 in Additional data file 1),
suggesting that a combined loss of function in these genes
might affect trophic supply to synaptic growth.
Analysis of synaptic growth in mutants of genes differentially regulated in ewgl1mutants Figure 5
Analysis of synaptic growth in mutants of genes differentially regulated in ewgl1mutants. (a,b) Quantification of synaptic growth in mutants of genes 
differentially regulated in ewgl1mutants. Type 1b boutons at muscle 13 were quantified and are shown as means with standard error (n = 18-22) in 
transheterozygotes for either a chromosomal deficiency or a second allele from mutants of genes down-regulated (a) or up-regulated (b) in ewgl1mutants 
that were significantly different (ap ? 0.0001, bp ? 0.001, cp ? 0.05) compared to controls (y w and y w transheterozygous for the corresponding 
chromosomal deficiency) except for genes involved in basal metabolism. Detailed genotypes with corresponding bouton numbers are listed in Table S2 in 
Additional data file 1. Genes are clustered according to their function with the color codes used in Figure 4. Note that genes down-regulated in 
ewgl1mutants are highly enriched for expression in the nervous system (90%) while only a minor portion of genes up-regulated in ewgl1mutants is 
expressed in the nervous system (36%). (c) Summary of mutants in genes differentially regulated in ewgl1mutants with synaptic growth defects and model 
of EWG regulation of these genes and their roles in synaptic growth regulation. CNS, central nervous system; PNS, peripheral nervous system.
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Gene Bouton Function, expression in stage 12-16 embryos
number
Control 12.7 ± 0.3
CG12299 15.0 ± 0.24
a Transciption factor, CNS
gro 16.6 ± 0.19a Transcriptional repressor, CNS, PNS
CG8924 18.7 ± 0.37a Transcription factor, ubiquitous
CG1832 17.1 ± 0.34a Transcription factor, CNS
CG6297 16.3 ± 0.3a Histone H3 kinase, n.d.
osk 15.0 ± 0.48
a RNA binding, muscle
Ac3 17.7 ± 0.34
a Adenylyl cyclase, CNS
cdc16 15.2 ± 0.34 a Ubiquitin protein ligase, n.d.
CG8436 19.0 ± 0.38
a Unknown, ubiquitous
Bcl7-like 18.6 ± 0.4 a Unknown, CNS
CG4916 9.4 ± 0.25
a DEAD/DEAH RNA helicase, no staining
Pinin 7.2 ± 0.32 a Splice factor, muscle primordia
swa 9.5 ± 1.3
a RNA binding, no staining
CG4771 8.9 ± 0.22
a RNA binding, no staining
otefin 9.5 ± 0.3
a Nuclear membrane component, CNS
CG2926 10.2 ± 0.29
a Nucleic acid binding, CNS
CG8589 7.8 ± 0.25
a RNA binding, CNS
Sd 8.0 ± 0.2 a   RAN GTPase, nuclear export,CNS
CG12750 10.7 ± 0.35
c RNA binding, CNS, salivary gland
Rox8 8.0 ± 0.27 a RNA binding, CNS, epidermis, proventr.
H 7.9 ± 0.38
a Transcriptional corepressor, CNS, PNS
CG13440 8.9 ± 0.22 a Ecysone reg. transcription, n.d.
CG4184 7.7 ± 0.33 a dArc105, PolII transcription mediator, n.d.
CG9241 9.6 ± 0.42 a Chromatin remodelling, n.d.
CG7471 8.5 ± 0.32 a Histon H3 deacetylase, CNS
CG12109 8.2 ± 0.28 a Caf1-180, chromatin assembly factor1, n.d.
CG14217 9.85 ± 0.32a Ser/Thr kinase, microtubule regulator, CNS
asp 8.4 ± 0.42 a Microtubule bound kinase, CNS
CG5807 8.4 ± 0.36
a Lipocalin, lipid binding, n.d.
CG1515 9.2 ± 0.4 a Membrane fusion, n.d.
CG7646 8.4 ± 0.64
a Neurocalcin, no staining
CG3431 10.8 ± 0.3 b Ubiquitine hydrolase, CNS, gut
CG5300 10.6 ± 0.32a Kinesin-like 31E, no staining
CG13599 8.1 ± 0.22
c Unknown, n.d.
Gene Bouton Function, expression in stage 12-16 embryos
number
Control 12.7 ± 0.3
18wheeler 16.8 ± 0.54
a Cell adhesion,cytokine signalling,CNS,gut
lambik 19.7 ± 0.58 a Cell adhesion, n.d.
Gliotactin 19.1 ± 0.25
a Cell adhesion, septate junction, ubiquitous
CG10077 16.0 ± 0.34 b RNA helicase, CNS
CG11212 5.8 ± 0.26
a Patched related receptor, n.d.
CG6724 7.5 ± 0.36a WD repeat adaptor protein, muscle
CG9847 8.6 ± 0.34
a Prolyl cis-trans isomerase, n.d.
miple2 8.5 ± 0.35
a Dmidkine2, muscle, gut
CG4115 11.5 ± 0.36
b Cell adhesion, epidermis
CG4445 9.9 ± 0.26
a GalNAc transferase3, n.d.
CG7896 11.2 ± 0.26
a Cell adhesion, n.d.
CG3800 11.2 ± 0.4
b Transcription factor, epidermis, gut
ken 8.5 ± 0.34
a Transcription factor, epidermis, gut
CG4758 10.3 ± 0.35b SRP dependent membrane targeting, muscle
CG32701 9 ± 0.29
a ER directed protein synthesis, epidermis
henna 8.3 ± 0.39a Phenylalanin hydroxylase, epidermis, CNShttp://genomebiology.com/2008/9/4/R73 Genome Biology 2008,     Volume 9, Issue 4, Article R73       Haussmann et al. R73.9
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Next, we validated functional connections among genes
down-regulated in ewgl1mutants with a synaptic overgrowth
phenotype in another assay. One of the genes in this class is
gro, for which hypomorphic alleles are known that are asso-
ciated with an overproliferation of frontal bristles on the head
(Figure 6b). gro has been described as a transcriptional co-
repressor that interacts with a subset of negative transcrip-
tional regulators [38]. We therefore tested a representative
number of mutants in genes downregulated in ewgl1mutants
in combination with gro for a change of the gro bristle pheno-
type. All mutants tested genetically interacted with gro,
resulting in either an enhancement or suppression of the gro
bristle phenotype (Figure 6e). None of the single mutants had
more bristles, but some had less (Figure 6d), suggesting that
the gro phenotype can be suppressed (for example, CG8924
and Bcl7-like), indicated by several roles of gro in peripheral
nervous system specification [39]. With quantitative RT-
PCR, we verified differential expression of these genes in
ewgl1mutants and rescue to wild-type expression levels by the
presence of an elav-EWG transgene in ewgl1mutants (Figure
6f). The genes are also expressed predominantly in the ven-
tral nerve cord (Figure S3 in Additional data file 1; Figure 4c)
[40]. Taken together, these data strongly suggest that these
genes down-regulated in ewgl1mutants are functionally con-
nected and operate in a common pathway.
erect wing genetically interacts with Notch and Wnt/
Wingless signaling in synaptic growth regulation
The predominance of transcriptional and post-transcrip-
tional regulators among genes differentially regulated in
ewgl1mutants, together with opposite phenotypes associated
with mutants of these genes, suggests that overlapping stim-
ulatory and restrictive pathways are integrated by an exten-
sive regulatory gene network. This model for the regulation of
synaptic growth implies that signaling pathways converge in
the regulation of gene expression and predicts that ewg
genetically interacts with several signaling pathways involved
in regulating synaptic growth.
Groucho, the protein encoded by gro, is differentially regu-
lated in ewg mutants and acts in both N and Wg signaling
pathways [39,41,42]. Since Wg was previously shown to reg-
ulate synaptic growth [43], we first determined if N is also
involved in regulating synaptic growth and second, if ewg
genetically interacts with these two pathways. Therefore, we
quantified type Ib bouton numbers at muscle 13 of third
instar NMJs in the absence or presence of EWG using the
eFeG transgene (Figure 1). In this genetic condition, half of
the mosaic animals will have one copy of the wild-type ewg
gene in clones while the other half contains the ewgl1null
allele and, therefore, has no EWG protein in clones. Changes
in N signaling were achieved through the recombined eFeG
transgene that expresses GAL4 in the clone and drives either
UAS-N for N overexpression or UAS-N-RNAi for N down-reg-
ulation. Expression of UAS-N-RNAi in post-mitotic neurons
has previously been shown to reduce N levels and to result in
long-term memory deficits [11-13]. Changes in wg signaling
in clones was achieved through overexpression from UAS
transgenes of wg or pangolin (pan), the transcription factor
intracellularly mediating the canonical wingless signal in
embryos and wing discs [44-46].
Similar to ewg, N restricts synaptic growth, resulting in
increased bouton numbers indicated by down-regulation of N
with RNA interference during larval life (from two independ-
ent UAS inserts, p = 0.005 for bar 1 compared with bar 4, Fig-
ure 7a) or in reduced bouton numbers when N was
overexpressed (p < 0.0001 for bar 1 compared with bar 6, Fig-
ure 7a) compared to wild-type control.
In the absence of EWG, removing N (N LOF) resulted in inter-
mediate numbers of boutons compared to wild type and ewg
LOF (p < 0.0001 for bar 5 compared with bar 1 and 2, Figure
7a). The increase in bouton numbers in N LOF (bar 5 com-
pared with bar 2) is not additive to the numbers observed in
the absence of EWG (bar 2 compared to bar 1, as seen for AP-
1 overexpression, see below), suggesting that regulation of
synaptic growth by N is not independent of ewg and indicat-
ing that part of the N signal is required for the full effect seen
in ewg LOF. Overexpression of N (N GOF) in the absence of
EWG resulted in intermediate numbers of boutons compared
to wild type and ewg LOF (p < 0.0001 for bar 7 compared
with bars 1 and 2, Figure 7a).
Overexpression of wg increased bouton numbers (p < 0.0001
for bar 1 compared with bar 8, Figure 7b), as previously
observed [43]. Overexpression of pan  also resulted in
increased bouton numbers (p < 0.0001 for bar 1 compared
with bar 10, Figure 7b), demonstrating that the canonical wg
pathway operates presynaptically to stimulate synaptic
growth.
In the absence of EWG, overexpression of both wg and pan
were epistatic to ewg  LOF and bouton numbers were
significantly reduced compared to ewg LOF (p ≤ 0.0001 for
bar 2 compared with bars 9 and 11, Figure 7b).
AP-1 and TGF-? act together with erect wing in synaptic 
growth regulation
The fos and jun heterodimer AP-1, and TGF-β signaling com-
prise two other known pathways involved in regulating
synaptic growth [4,5,7,8]. Both AP-1 and TGF-β stimulate
synaptic growth compared to wild type as evident either by
overexpression of fos and jun together (p < 0.0001 for bar 1
compared with bar 12, Figure 7c) and an activated BMP type
I receptor (tkvA, from two copies of UAS-tkvA, p < 0.0001 for
bar 1 compared with bar 16, Figure 7d), or by removal of AP-
1 activity through overexpression of a dominant negative
form of jun (junBZ, p < 0.0001 for bar 1 compared with bar
14, Figure 7c), or in the BMP type II receptor mutant wishful
thinking (wit, p < 0.0001 for bar 1 compared with bar 18, Fig-
ure 7d), which is largely in agreement with previous observa-Genome Biology 2008, 9:R73
http://genomebiology.com/2008/9/4/R73 Genome Biology 2008,     Volume 9, Issue 4, Article R73       Haussmann et al. R73.10
Validation of functional relationships of ewg co-regulated genes by genetic interactions Figure 6
Validation of functional relationships of ewg co-regulated genes by genetic interactions. (a-d) Top view of head and thorax of wild type, gro and Ac3 
mutants, and gro Ac3 double mutants. Note the strong overproliferation of frontal bristle on the head and humeral bristles on the thorax of gro Ac3 double 
mutants compared to gro mutants (arrowheads). Some Ac3 mutants, as shown in (d), have a reduced number of frontal bristles (arrowhead). Deficiencies 
used are listed in Table S2 in Additional data file 1. The scale bar in (a) represents 100 μm. (e) Analysis of frontal bristle numbers in single and double 
mutants of genes down-regulated in ewgl1mutants with a synaptic overgrowth phenotype. Note that in all double mutants tested the frontal bristle 
phenotype is either enhanced or suppressed. Deficiencies used are listed in Table S2 in Additional data file 1. (f) Quantitative RT-PCR of genes down-
regulated in ewgl1mutants with a synaptic overgrowth phenotype. PCR products using 32P labeled forward primers from cycle 26 were analyzed on 6% 
polyacrylamide gels. elav: control (cycle 28).
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tions [4,5,7,8]. Overexpression of either fos or jun alone has
no effect on synaptic growth [4] (and data not shown).
Next, we wanted to define how these two pathways relate to
ewg mediated regulation of synaptic growth. In the absence
of EWG, overexpression of AP-1 is additive and further
increases bouton numbers significantly (p < 0.0001 for bar 13
compared with bars 2 and 12, Figure 7c). Inhibiting AP-1
function by expressing the dominant negative junBZ com-
pletely removes the stimulatory effect of ewg  LOF (p  <
0.0001 for bar 15 compared with bars 2 and 13, and non-sig-
nificant for bar 15 compared to bar 14, Figure 7c), suggesting
that AP-1 functions downstream of ewg.
Overexpression of tkvA (from two copies of UAS-tkvA) in ewg
LOF resulted in intermediate numbers of boutons compared
to wild type and ewg LOF (p < 0.0001 for bar 17 compared
with bars 1 and 2, Figure 7d), indicating that the TGF-β sign-
aling pathway does not act independent of ewg in synaptic
growth regulation. Removal of the BMP type II receptor wit
significantly reduced bouton numbers in ewg  LOF (p  <
0.0001 for bar 19 compared with bars 2 and 17, Figure 7d).
The strong reduction of bouton numbers in wit mutants in
ewg LOF compared to wild type (p < 0.0001 for bar 19 com-
pared with bar 1, Figure 7d) further suggests that TGF-β sig-
naling also includes a component that acts downstream of
ewg.
Discussion
Several pathways have been identified that stimulate synaptic
growth at NMJs of Drosophila larvae (Wnt/Wingless, TGF-
β/BMP and jun kinase) [2-4]. Overexpression of AP-1 [4] and
mutants in regulatory genes involved in Wnt/Wingless and
TGF-β/BMP pathways (spinster, highwire, shaggy and the
proteasome) [9,47-49] can increase bouton numbers, sug-
gesting that synaptic growth is regulated through the balance
of stimulatory and restrictive signals. Here, we have
identified such a restrictive role for the transcription factor
EWG and, through the analysis of EWG-regulated genes, for
the N pathway in the regulation of synaptic growth. Using
genetic mosaics, we further demonstrate that EWG's role in
synaptic growth regulation is cell-autonomous, suggesting
that the transcriptional regulator EWG mediates this
restrictive effect through the alteration of transcription pre-
synaptically.
Analysis of genes differentially expressed in ewgl1mutants
revealed a rather unexpected set of genes involved in synaptic
growth regulation, besides an expected number of metabolic
genes due to homology of EWG to human NRF-1 [50]. Most
genes that could account for the phenotype of ewgl1mutants,
and that are thus expressed in the nervous system, are
involved in transcriptional and post-transcriptional regula-
tion of gene expression. Although changes of transcript levels
in ewgl1mutants were mostly moderate, their significance was
validated through mRNA profiling with rescued
ewgl1mutants under the same conditions of RNA preparation
and microarray hybridization. In addition, differences in gene
expression in ewgl1mutants were validated using quantitative
RT-PCR and biochemic a l  a s s a y s  w i t h  r e g a r d  t o  p r e d i c t e d
changes in glycogen levels based on differential regulation of
genes involved in gluconeogenesis (for example, Pepck; Addi-
tional data file 1). Furthermore, genetic interaction experi-
ments in double mutants with increased bouton numbers
support that these co-regulated genes are functionally con-
nected in regulating synaptic growth.
The group of neuronal genes among those differentially regu-
lated in ewgl1mutants that have been demonstrated to have
roles in synaptic growth or could account for it, is remarkably
small. In particular, from the large number of cell adhesion
molecules and cytoskeletal proteins present in the Dro-
sophila  genome only a handful is differentially regulated.
Similar results have also been obtained in response to JNK
and AP-1 signaling [15]. These results are in contrast to
changes in gene expression induced by acute or chronically
enhanced neuronal activity in Drosophila seizure mutants,
which also result in synaptic overgrowth [51]. Here, the vast
majority of differentially regulated genes are for cell adhesion
molecules and cytoskeletal proteins or their regulators, and
genes involved in synaptic transmission and neuronal excita-
bility; transcriptional or post-transcriptional regulators com-
prise only a minor portion. These differences could be
explained by separate pathways regulating growth independ-
ent of neuronal activity [36,52] (and this study).
Particularly striking is the large number of genes involved in
RNA processing among genes differentially expressed in
ewgl1mutants. Although local regulation of gene expression is
required in growth cones of navigating axons, a prominent
role for pre-synaptic regulation of gene expression at the RNA
level is only just emerging [53], but is a hallmark of post-syn-
aptic plasticity [29,54]. Several RNA binding proteins have
been implicated in memory storage [23,55,56]. osk and CPSF
(cleavage and polyadenylation specificity factor) are among
the genes differentially regulated in ewgl1mutants. Other
genes involved in RNA processing differentially regulated in
ewgl1mutants comprise the whole spectrum of regulation at
the post-transcriptional level, from nuclear organization (ote-
fin), alternative pre-mRNA processing (Pinin, CPSF, Rox8)
and export/import (Segregetion distorter, Nxf2, CG11092,
Karyopherin,  Transportin) to transport, localization and
translation (oskar, swallow, ribosomal protein genes S5 and
Rpl24), and likely also include the regulation of mRNA stabil-
ity (Rox8).
An intriguing connection between ewg and signaling path-
ways involved in regulating synaptic growth is indicated by
differentially regulated components of the Wg and N path-
ways (gro and Hairless) [39,41,42,57] in ewgl1mutants. Con-
sistent with a role of the co-repressor gro  in Wg and NGenome Biology 2008, 9:R73
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mediated transcriptional regulation of synaptic growth, Wg
and N signaling pathways do not operate independently of
ewg in genetic interaction experiments. The transcriptional
regulatory networks of EWG, Wg and N seem to be highly
interwoven. Overexpression of pan, the transcriptional medi-
ator of canonical Wg signaling, which is repressed by gro,
does not lead to a further expansion of synaptic growth in ewg
mutants, suggesting a requirement for ewg-regulated genes.
This effect could be mediated by deregulated N signaling,
which is also repressed by gro, but antagonistic to Wg in syn-
aptic growth. Thus, removal of gro, as in ewg, will relieve the
repressive effect of N and antagonize the stimulatory effect of
pan. In the complementary situation, removal of N increased
bouton numbers further in the absence of EWG, which is con-
sistent with an increase in Wg signaling as a result of down-
regulated gro in ewg mutants. Antagonism between N and
Wg pathways has also been found in wing discs, where N
inhibits armadillo (arm), the transcriptional co-activator of
canonical Wg signaling [58]. Intriguingly, gro has also been
found to be a target of receptor tyrosine kinase signaling and,
thus, can combine additional pathways with N and Wg sign-
aling [59,60]. In addition to transcriptional hierarchies, chro-
matin remodeling has also been implicated in synaptic
plasticity [61]. Strikingly, CG6297, a Drosophila homologue
of the histone deacetylase RPD3, is differentially expressed in
ewgl1mutants and physically interacts with gro [62].
How ewg exerts its effect on TGF-β signaling is less clear. A
prominent regulatory step in this pathway is the regulated
degradation of the SMAD co-factor Medea by Highwire [5].
Several genes involved in regulating protein stability are dif-
ferentially down-regulated in ewg  mutants (CG6759,
CG3431, CG4973, CG7288, CG3455, CG9327 and CG9556).
Lower expression levels of these genes might interfere with
stabilization of Medea and explain why the effect of activated
TGF-β signaling is not additive in the absence of EWG (tkvA
GOF ewg LOF). Bouton numbers in wit  null mutants are
marginally increased in the absence of EWG, suggesting
further that genes regulated by SMADs are involved in medi-
ating synaptic overgrowth in ewgl1mutants. Potentially, ewg
could also regulate TGF-β signaling through the endosomal
pathway involving spinster and/or spichthyin [9,63].
Functionally related genes have been shown to be co-regu-
lated [37], suggesting additional ELAV targets in EWG-regu-
lated gene networks. Indeed, ELAV negatively regulates
alternative splicing of the penultimate exon in armadillo
(arm) [19]. Exclusion of this exon, which truncates the car-
boxyl terminus of arm, reduces Wg signal transduction,
which is in agreement with ewg's antagonistic role relative to
Wg signaling. Another known ELAV target gene is neuroglian
(nrg), where a role in synapse formation has recently been
demonstrated in the giant fiber system [64]. Taken together,
the establishment of a gene network regulated by EWG will
now serve as valuable tool to identify further ELAV regulated
modules that shape the synapse.
Conclusion
The transcription factor EWG is a major target of the RNA
binding protein ELAV, which regulates EWG protein expres-
sion via a splicing mechanism. EWG is required pre-synapti-
cally and cell-autonomously at third instar neuromuscular
junctions to restrict synaptic growth, demonstrating that
restrictive activities at gene expression levels are also
required for synaptic growth regulation. EWG mediates regu-
lation of synaptic growth primarily by increasing transcript
levels of genes involved in transcriptional and post-transcrip-
tional regulation of gene expression. Genes at the end of the
gene expression hierarchy (effector genes) represent only a
minor portion of EWG-regulated genes. Since analysis of
mutants in genes differentially regulated in ewgl1mutants
revealed that these genes are involved in both stimulatory and
restrictive pathways of synaptic growth, and since ewg genet-
ically interacts with a number of signaling pathways (Wing-
less, Notch, TGF-β and AP-1), our results suggest that
synaptic growth in Drosophila is regulated by the interplay of
multiple signaling pathways rather than through independ-
ent pathways.
Materials and methods
Fly genetics, recombinant DNA technology and 
microarrays
Fly breeding, genetics and P-element mediated transforma-
tion of Drosophila, and recombinant DNA technology were
erect wing integrates cellular signaling to regulate synaptic growth Figure 7 (see following page)
erect wing integrates cellular signaling to regulate synaptic growth. (a-d) Genetic interaction of ewg with known signaling pathways in synaptic growth 
regulation. Synaptic growth was analyzed at third instar NMJs by quantifying type 1b boutons at muscle 13 of ewgl1eFeG clones (white bars and '-' at the 
bottom of the column) or of ewgl1eFeG clones in the presence of an ewg wild-type copy (grey bars and '+' at the bottom of the column) in combination 
with either transgenes for UAS constructs or transheterozygous combinations of mutant alleles (witA12/witB11) as described for Figure 1. Wild type (bar 1), 
ewg loss of function (LOF, bar 2) and ewg gain of function (GOF, black bars, bar 3) were compared to LOF and GOF mutants in Notch (a), Wingless (b), 
AP-1 (c) and TGF-?/BMP (d) pathways. Overexpression of N is shown in the presence of both ewg copies ('++' at the bottom of the column), as one ewg 
copy in the presence of excess N does not result in a significant increase of bouton numbers compared to wild type. For both N and tkvA, two copies of 
UAS transgenes were used; a single copy did not significantly alter bouton numbers. Shown are means of bouton numbers with standard errors (n = 11-23, 
numbers at the bottom of bars). Bars are numbered below the x-axis. Statistical significance of differences from comparisons with wild type is shown on 
top of bars (***p < 0.0001, ** p < 0.005, n.s. for non significant). Other relevant comparisons are marked by horizontal bars with the statistical significance 
indicated on the side.http://genomebiology.com/2008/9/4/R73 Genome Biology 2008,     Volume 9, Issue 4, Article R73       Haussmann et al. R73.13
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Figure 7 (see legend on previous page)
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done according to standard procedures as detailed in Soller
and White [21] and Soller et al. [65]. In all experiments the
ewg NS isoform was used [24]. The eFeG construct P{w+ =
elav-FRT-EWG-FRT-GAL4} is basically the same as the
EWGNS construct [25] except that the ewg cDNA is flanked by
FRT sites followed by the coding sequence of the yeast GAL4
transcription factor.
For cloning of the eFeG construct, the 3.5 kb elav promoter
[25] was cloned into a linker modified CaSpeR 4 (Drosophila
Genomics Resource Center, Bloomington, IN, USA) with a
blunt  EcoRI site and NotI site to generate the construct
C4MMelav2. The 5' FRT site was added to the ewg gene by
nested PCR with primers FRTewgF1
(AGAAAGTATAGGAACTTCAGAGCGCTTTTGAAGCTAgcccac
cgccaaactggccaccacaagc; the ewg  sequence is indicated in
small letters and restriction sites are underlined) and
FRTewgF2
(CGGGGATCTTGAAGTTCCTATTCCGAAGTTCCTATTCTCT
AGAAAGTATAGGAACTTCAGAGCGC) and ewg3cR1Spe
(GGAACTAGTCAACACCTTGAACCTGGGCAGTTGTAC-
CATCC) and cloned into C4MMelav2 with a blunt NotI site
and SpeI site to generate C4MMelavFRTewg. For cloning of
the 3' part of eFeG, a HpaI-EcoRI fragment encoding the 3'
part of the ewg cDNA was cloned into pBluescript (Strata-
gene, Cedar Creek, TX, USA) cut with EcoRV and EcoRI to
generate SC3HE. Subsequently, the 3' FRT site was cloned
into  SC3HE  cut with EcoRI and SacII with two
oligonucleotides (FRT-A EcoRI x NotI,  SpeI,  SacII:
AATTCCGGGGATCTTGAAGTTCCTATTCCGAAGTTCCTAT
TCTCTAGAAAGTATAGGAACTTCAGAGCGCTTTT-
GAAGCT GCGGCCGCACTAGTGC and FRT-B:
ACTAGTGCGGCCGCAGCTTCAAAAGCGCTCTGAAGTTCC
TATACTTTCTAGAGAATAGGAACTTCGGAATAGGAACT-
TCA AGATCCCCGG) after the ewg 3' untranslated region
(UTR) to generate SC3HE FRT. GAL4 with the hsp70 3' UTR
from pGaTN (Drosophila Genomics Resource Center) was
cloned with NotI and SpeI into SC3HE FRT to generate eFG.
From eFG, the 3' part of ewg, the FRT site and the GAL were
cloned with Acc65I and SpeI into C4MMelavFRTewg to gen-
erate the eFeG construct.
For the analysis of synaptic growth in EWG deficient neurons,
two independent inserts of the eFeG construct on the X and
third chromosomes that fully rescue ewgl1mutants were used.
To induce clones with eFeG transgenes, 14-18 h old embryos
from ewgl1eFeG females crossed with males carrying hs-flp
UAS-CD8::GFP (P{hsFLP}38,  P{UAS-mCD8::GFP.L}LL5
[66,67]) on the second chromosome were heat shocked for 45
minutes at 35°C, rested for 45 minutes at room temperature
and incubated for another 45 minutes at 37°C. For genetic
interaction experiments, the ewgl1eFeG  and  hs-flp UAS-
CD8::GFP chromosomes were combined with the following
UAS transgenes or mutants (from Bloomington stock center,
Bloomington, IN, USA) or as noted: UAS-wg  (second or
third, P{w [+mC] = UAS-wg.H.T:HA1}6C and P{w [+mC] =
UAS-wg.H.T:HA1}3C [45]), UAS-pan (second or third, P{w
[+mC] = UAS-pan.dTCF}24 and  P{w [+mC] = UAS-
pan.dTCF}4 [45]), UAS-N-RNAii (second and/or third, P{w
[+mC] = UAS-N.dsRNA.P}14A and  P{w [+mC] = UAS-
N.dsRNA.P}9G [13]), UAS-N (second and/or third, gift form
S Artavanis-Tsakonas [68]), UAS-tkvA (second and/or third,
gift from M O'Connor [7]), UAS-junBZ  (second or third,
P{Jbz}1 and P{Jbz}10 [69]), UAS-fos (P{UAS-Fra}, second
[69]),  UAS-jun  (P{UAS-Jra}2, third [69]) and witA12 with
witB11 [8], UAS-Tetanustoxin (gift from S Sweeney, P{UAS-
TeTxLC.tnt}, CNT-E, second [70]). Overexpression of UAS-
wg, UAS-pan, UAS-N-RNAi and UAS-N with elav-GS-GAL4
(third, P{elav-Switch.O} [27]) resulted in significant changes
in bouton numbers comparable with overexpression with
recombined eFeG compared to wild type.
The elav-NRF-1 construct was made by exchanging the ewg
open reading frame (ORF) in elav-EWG  with the ORF of
NRF-1 as follows. The NRF-1 ORF was amplified by PCR with
primers NRF-F1 (TAGAGCGGCCGCTCGAGAATTCtttacgt-
ggtcctttatttg) and NRF-R1 (CATGCCTTCTATGGGCTCCAgT-
CACTGTTCCAATGTCACCACCTC) from a cDNA clone (gift
from R Scarpulla [18]), cut with NotI and combined with the
3' UTR of ewg amplified by PCR with primers ewgUTR-F1
(ctggagcccatagaaggcatg) and M13rev (GGAAACAGCTAT-
GACCATG) from the ewg cDNA clone in pBluscript SK+ cut
with SpeI and with the C4MMelav2 cut with NotI and SpeI in
a three way ligation to generate C4MMelav2NRF-1. NRF-1
expression was verified in transgenes by western blots.
Inserts of elav-NRF-1 on the second and third chromosomes
were used. elav-ELAV is the elav ORF under the control of the
endogenous promoter followed by an α-tubulin 3' UTR, and
the elav-NRF-1 insert on the second chromosome was used
[25]. For the UAS-ewg construct, the NS isoform (EWGNS)
including the ewg 3' UTR [25] was cloned with BamHI and
SpeI into a modified pUAST  [71] cut with BglII and SpeI
where the SV40 3' UTR had been removed. Conditional over-
expression of EWG from UAS-ewg  (third) with elav-GS-
GAL4 (elav-GeneSwitch-GAL4 [27]) (third) was induced by
adding RU486 (Mifepristone, Sigma, St Louis, MI, USA) in
100 μl of 50% ethanol to larvae two days before dissection
[27]. The elav  alleles used were elavts1, a temperature
sensitive allele, and elave5, a null allele [71]. Mutants used in
genes differentially regulated in ewgl1mutants are listed in
Table S2 in Additional data file 1 and were obtained from
Bloomington, Harvard and Tübingen stock centers as indi-
cated in Flybase [72].
Embryos for microarray analysis were produced by crossing
ewgl1/C155-GAL4; UAS-GFP/+ females to C155-GAL4; UAS-
GFP  males (P{GawB}elavC155;  P{UAS-GFP.S65T}T2
[65,73]). The X-chromosomal C155-GAL4 enhancer trap was
inserted in the neighboring elav gene and drives GFP expres-
sion in neurons and neuroblast [65]. From the progeny of this
cross, non-GFP expressing embryos, which are male, were
then hand-picked 16-18 h after egg laying and RNA washttp://genomebiology.com/2008/9/4/R73 Genome Biology 2008,     Volume 9, Issue 4, Article R73       Haussmann et al. R73.15
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extracted from pools of 50 embryos with Trizol (Invitrogen,
Carlsbad, CA, USA). Pooled RNA from a total of 300 embryos
was then reverse-transcribed with an oligo-dT primer con-
taining a T7 promoter and, after the synthesis of the second
strand, linearly amplified by in vitro transcription with T7
RNA polymerase and labeled with biotinylated NTPs accord-
ing to the manufacturers instructions (Genechip Protocol for
Eukaryotic Target preparation, Affymetrix, Santa Clara, CA,
USA) yielding between 20 and 50 μg of RNA. Amplified RNA
(15 μg) including spike controls was hybridized to Affymetrix
Drosophila genome arrays Version X using the Affymetrix
Gene Chip Instrument System overnight at 42°C. Arrays were
washed and stained with streptavidin-phycoerythrin before
scanning on an Affymetrix Gene Chip scanner.
Quantitative RT-PCR was done with 5' 32P labeled forward
primers and PCR products from unsaturated cycles (24, 26,
28 or 30 depending on expression levels of a particular gene)
were analyzed on 6% polyacrylamide gels essentially as previ-
ously described [19]. Primer sequences are available upon
request.
Microarray data analysis
Gene chip data were analyzed using the software packages
MAS version 5 (Affymetrix) and dChip. Scanned data were
first processed with MAS to convert raw image files (.DAT) to
probe signal values files (.Cel). Probe signal files were nor-
malized across samples using dChip invariant set method.
Summary values for each probe set were calculated with PM-
only model in dChip. Microarray data have been deposited in
MIAMExpress [74] under the accession number E-MEXP-
1312.
Western blotting, RNA in situ hybridization, 
immunostaining and statistics
Western blotting was done as previously described [24].
Quantification of western blots was done with Quantity ONE
4.2.3 (Bio-Rad, Hercules, CA, USA). RNA in situ hybridiza-
tions were done according to the BDGP protocol, or obtained
from the BDGP web page [75]. For the analysis of NMJs, wan-
dering third instar larvae were dissected in phosphate-buff-
ered saline and fixed with 4% formaldehyde for 30 minutes.
The following antibodies were used: anti-DSYT (1:200; gift
from T Littelton [26]), anti-DLG (1:100; gift from V Budnik
[76]), anti-CSP (1:100; gift from K Zinsmaier [77]), anti-Nc82
(1:6; Developmental Studies Hybridoma Bank), anti-High-
wire (1:6; Developmental Studies Hybridoma Bank),
Mab22C10 (1:200; Developmental Studies Hybridoma
Bank), FITC conjugated anti-HRP (1:200; Cappel, Cochran-
ville, PA, USA), FITC conjugated anti-CD8 (1:200; Cappel).
FITC, TRITC (Jackson Labs, Bar Harbor, MA, USA) and Cas-
cade Blue (Molecular Probes, Eugene, OR, USA) conjugated
secondary antibodies were used 1:200. Confocal images were
acquired at 18°C using a Leica TCS SP2 confocal scanning
microscope with a Plan APO HC 10 × 0.4 numerical aperture
objective for eye discs, or under oil with a Plan APO HCX 63
× 1.4 numerical aperture (NMJs) or a Plan APO HCX 100 ×
1.4 numerical aperture (single boutons) objective and Leica
software. Image files were converted to TIFF and merged
using Photoshop CS2 (Adobe). Levels of individual channels
were adjusted where applicable to maximize pixel range. Flies
were photographed with a digital camera (Nikon) on a Leica
Stereoscope at 3× magnification. Statistical analysis of bou-
ton numbers was done with ANOVA followed by post hoc
analysis with Fisher's PLSD (protected least significant differ-
ence) for multiple comparisons, or with t-test for two sam-
ples, using StatView.
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